SMS Pharmaceuticals · NSE: SMSPHARMA · BSE: 532815
Q1 FY19 results · Apr–Jun 2018
SMS Pharmaceuticals reported revenue from operations of ₹125.11 crore and net profit of ₹10.11 crore for Q1 FY19 (Apr–Jun 2018), on a standalone basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 125.11 | — | — | — | — |
| Other income | 0.36 | — | — | — | — |
| Total income | 125.47 | — | — | — | — |
| Profit before tax | 16.29 | — | — | — | — |
| Net profit for the period | 10.11 | — | — | — | — |
| EPS, basic (₹) | 1.19 | — | — | — | — |
| Net margin (%) | 8.1 | — | — |
Standalone
- Filed with BSE
- 30 Jul 2018, 15:34 IST
- Board meeting
- 28 Jul 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE